Clinical trial
ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to…
NCT00004926 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004926 |
|---|---|
| Title | ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy |
| Official title | A Phase I Study of Oral ILX23-7553 in Patients With Solid Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement |
| Interventions | vitamin D3 analogue ILX23-7553 |
| Start date | Oct 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Dec 1, 2009 |
| First posted | Mar 16, 2004 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: